台股 » 個股 » 太景*-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

太景*-KY

(4157)
可現股當沖
  • 股價
    15.05
  • 漲跌
    ▼0.25
  • 漲幅
    -1.63%
  • 成交量
    1,748
  • 產業
    上櫃 生技醫療類股
  • 263人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
太景*-KY (4157)籌碼相關-富邦-信義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-信義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2900.00215.3515.65-22,407-0.08%
2024/04/2600.00115.4015.40-12,370-0.04%
2024/04/23115.7000.0015.5012,2950.04%
2024/04/2200.002015.8515.60-202,247-0.89%
2024/04/19416.7300.0016.4542,0410.20%
2024/04/182015.7500.0015.75201,6211.23%
2024/04/1000.002015.2515.10-201,428-1.40%
2024/04/0100.00515.6515.70-51,403-0.36%
2024/03/29515.4500.0015.4551,3650.37%
2024/03/2500.001015.6015.40-101,273-0.79%
2024/03/20514.5000.0014.3551,2380.40%
2024/03/121015.1000.0014.90101,2670.79%
2024/02/1900.000.115.8515.50-0.11,835-0.01%
2024/01/2900.00315.0515.00-32,025-0.15%
2024/01/2200.000.115.4514.80-0.12,0270.00%
2024/01/1600.00015.4015.1002,0650.00%
2024/01/12115.3000.0015.2512,0630.05%
2024/01/090.515.4000.0015.250.52,0620.02%
2024/01/031015.301015.0015.0502,0090.00%
2023/12/151015.351015.3515.3001,9100.00%
2023/12/131015.401015.3015.3001,9170.00%
2023/12/121015.351015.2515.2501,9200.00%
2023/12/0400.0010316.8516.85-1031,707-6.03% 大賣/鉅額交易
2023/12/01316.401916.4516.05-161,527-1.05%
2023/11/3000.00215.8515.90-21,415-0.14%
2023/11/2700.00616.1516.20-61,187-0.51%
2023/11/1500.00114.8514.80-11,081-0.09%
2023/11/14314.5500.0014.7031,0830.28%
2023/11/130.114.9000.0014.800.11,0800.01%
2023/11/091015.701015.4015.4001,0630.00%
2023/11/06115.7500.0015.7511,0250.10%
2023/11/011014.951014.9514.9009060.00%
2023/10/180.114.3000.0014.150.19840.01%
2023/10/13514.5000.0014.5051,0680.47%
2023/09/20414.8000.0014.8042,5270.16%
2023/09/11114.9500.0014.9012,6470.04%
2023/08/30115.5000.0015.5512,9980.03%
2023/08/280.314.9000.0014.850.32,9740.01%
2023/08/2400.001014.8014.90-103,007-0.33%
2023/07/24515.7000.0015.6552,9040.17%
2023/07/2100.00116.0016.05-12,894-0.03%
2023/07/18115.8000.0015.7512,8760.03%
2023/07/17116.5500.0016.4512,8620.03%
2023/07/1300.00615.8015.70-62,854-0.21%
2023/07/112016.6500.0016.50202,7760.72%
2023/07/10616.7000.0016.7062,7480.22%
2023/07/072016.8000.0016.65202,7350.73%
2023/07/051017.201017.0017.0002,6400.00%
2023/07/041017.401617.1917.05-62,588-0.23%
2023/07/03118.1500.0018.0012,4420.04%
2023/06/29818.18418.1018.1042,0970.19%
2023/06/286016.901017.0017.20501,7022.94%
2023/06/271215.931216.0116.0501,5230.00%
2023/06/191015.951015.7515.7001,5910.00%
2023/06/161015.751115.8315.85-11,704-0.06%
2023/06/151015.651015.5715.6501,6960.00%
2023/06/12416.581716.1016.00-131,633-0.80%
2023/06/093315.721715.3115.35161,4571.10%
2023/06/0800.00214.8314.90-21,363-0.15%
2023/06/0500.00714.9014.90-71,396-0.50%
2023/05/3100.00115.0015.00-11,406-0.07%
2023/05/2300.00215.2015.25-21,413-0.14%
2023/05/2200.001015.0315.20-101,418-0.70%
2023/05/1500.001015.2015.05-101,438-0.70%
2023/05/0400.00515.7315.75-51,515-0.33%
太景*-KY流感抗病毒新藥三期臨床 提前完成收案750人Anue鉅亨-2024/01/08
太景*-KY 相關文章